Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while implementin...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2021-12-01
|
| סדרה: | Journal of Pharmaceutical Policy and Practice |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1186/s40545-021-00383-y |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|